Michael Arenberg
Geschäftsführer bei IMAGO BIOSCIENCES, INC.
Aktive Positionen von Michael Arenberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMAGO BIOSCIENCES, INC. | Geschäftsführer | 23.03.2022 | - |
Karriereverlauf von Michael Arenberg
Ehemalige bekannte Positionen von Michael Arenberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DURECT CORPORATION | Finanzdirektor/CFO | 15.10.2018 | 17.03.2022 |
| Investor Relations Kontakt | 01.01.1999 | 17.03.2022 | |
| Corporate Officer/Principal | 17.07.2009 | 15.10.2018 | |
| Unternehmenssekretär | - | 17.03.2022 | |
IntraEAR, Inc.
 IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Gründer | 01.01.1996 | 01.01.1999 |
| Vertrieb & Marketing | 01.01.1996 | 01.01.1999 |
Ausbildung von Michael Arenberg
| University of Denver | Graduate Degree |
| Leavey School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
IntraEAR, Inc.
IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Börse
- Insiders
- Michael Arenberg
- Erfahrung
